Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Westvac Biopharma Co., Ltd.

Clinical trials sponsored by Westvac Biopharma Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Experimental drug WSK-IM02 takes on Hard-to-Treat ovarian cancer Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 2

New hope for Drug-Resistant TB: experimental combo trial launches

Disease control Recruiting now

This study tests a new drug called JDB0131, combined with other TB medications, in 60 people with rifampin-resistant tuberculosis. Participants will receive one of two doses of JDB0131 or a standard drug (delamanid) for 8 weeks. The goal is to see which combination clears the bac…

Phase 2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC